Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitis
Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has received marketing authorization for abrocitinib in adults with moderate-to-severe atopic dermatitis from the Central Drugs Standard Control Organization (CDSCO). It is also approved by the USFDA, European Medicines Agency (EMA), and other regulatory agencies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2024 Category: Pharmaceuticals Source Type: news
Pfizer Reports Surprise Profit Despite Continued Covid Sales Downfall
stock sank early Tuesday after the pharma giant unexpectedly reported a fourth-quarter profit despite missing sales expectations. During the December quarter, Pfizer earned 10 cents per share, beating forecasts for an 18-cent loss per share. Earnings tumbled 91% year over year. Sales also plunged…#pfizer #thirdbridge #leebrown #daviddenton #prevnar #bristolmyerssquibb #bmy #medicare #rsv #abrysvo (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2024 Category: Consumer Health News Source Type: news
Pfizer Earnings Beat Estimates
As investor worries heightened last year over Covid-19 products’ waning demand, the company is taking steps to rev up sales including launching new ventures such as new drugs and vaccine approvals. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2024 Category: Consumer Health News Source Type: news
Pfizer's COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label
The FDA has updated the emergency use authorization (EUA) for Pfizer Inc’s PFE Paxlovid, impacting its distribution and use in treating mild-to-moderate COVID-19. In December 2021, the FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric patients who are at high risk…#fda #eua #pfizerincs #pfepaxlovid #pfizer #nda #ndalabeledpaxlovid #providers #paxcess #medicare (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2024 Category: Consumer Health News Source Type: news
Stock Market Today: Dow Set to Open Down; Market Movers
U.S. stock markets were diverging ahead of the open on Monday, with the market looking ahead to a packed earnings schedule and a Federal Reserve monetary-policy decision this week. Dow Jones Industrial Average futures were down 21 points, or 0.1%. S&P 500 futures were broadly flat, while Nasdaq…#federalreserve #nasdaq100 #fomc #ing #christurner #googleparent #alphabet #pfizer #generalmotors #starbucks (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2024 Category: Consumer Health News Source Type: news
U.S. Stock Futures Mixed with Focus on Earnings, Fed
U.S. stock markets were diverging ahead of the open on Monday, with the market looking ahead to a packed earnings schedule and a Federal Reserve monetary-policy decision this week. Dow Jones Industrial Average futures were down 21 points, or 0.1%. S&P 500 futures were broadly flat, while Nasdaq…#federalreserve #nasdaq100 #fomc #ing #christurner #googleparent #alphabet #pfizer #generalmotors #starbucks (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2024 Category: Consumer Health News Source Type: news
2 Ultra-High-Yield Dividend Stocks Down 47% or More to Buy Hand Over Fist Right Now
Does a rising tide lift all boats? Not always. The S&P 500 is now officially in a new bull market, but not every stock has benefited. Just because a stock is down doesn't mean it's not a good pick, though. That's especially the case when it pays you handsomely to wait for better days. Here are two…#devonenergy #importantly #devon #pfe #pfizer #cfo #davedenton #q3 #ibrance #seagen (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2024 Category: Consumer Health News Source Type: news
How The COVID Virus Defends Itself From The Human Immune System
Authored by Amie Dahnke via The Epoch Times (emphasis ours), Just how was the COVID-19 coronavirus so successful? (Naeblys/Shutterstock) The question has eluded scientists and medical professionals since the novel virus swept the…#amiedahnke #epochtimes #naeblysshutterstock #naturecommunications #kaitittmann #lisamariefunk #pfizer #fda (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2024 Category: Consumer Health News Source Type: news
China Says It Has Imprisoned Ian Stones, a British Businessman, on Spy Charges
A British businessman who disappeared from public view in China in 2018 was sentenced to five years in prison in 2022, China’s Foreign Ministry said on Friday, in its first public acknowledgment of the case. The businessman, Ian J. Stones, had lived in China since the 1970s, working for companies…#foreignministry #ianjstones #generalmotors #pfizer #wangwenbin (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2024 Category: Consumer Health News Source Type: news
China Says It Has Imprisoned Ian Stones, a British Businessman, on Spy Charges
A British businessman who disappeared from public view in China in 2018 was sentenced to five years in prison in 2022, China’s foreign ministry said on Friday, in its first public acknowledgment of the case. The businessman, Ian J. Stones, had lived in China since the 1970s, working for companies…#ianjstones #generalmotors #pfizer #foreignministry #wangwenbin (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2024 Category: Consumer Health News Source Type: news
3 Stocks to Sell Before Their Earnings Reports Disappoint in 2024
Watch for these stocks to sell before earnings are released Earnings season can have an outsized impact on a company’s share price, which means considering stocks to sell before earnings reports are released. Netflix (NASDAQ: ) reports great subscriber growth and its stock jumps 12% higher. 3M…#starbucks #q4 #sbux #beijing #pfizer #pfe #boeing #faa #max #joelbaglole (Source: Reuters: Health)
Source: Reuters: Health - January 25, 2024 Category: Consumer Health News Source Type: news
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs
These biotech stocks boast AI-supported pharmaceuticals and have promising financial prospects Integrating artificial intelligence and biotechnology could make 2024 a landmark year. The utilization of AI, machine learning and big data is nowadays a part of research and development (R&D) procedures…#insilicomedicine #fda #pfe #pfizer #eps #exai #exscientia #gsk #hongkong #bntx (Source: Reuters: Health)
Source: Reuters: Health - January 25, 2024 Category: Consumer Health News Source Type: news
Greenlight Establishes a New Top-Five Position
The value focused hedge fund manager told clients it established a number of new positions in the fourth quarter, including one that instantly landed among its top-five holdings, according to the fourth quarter letter from his hedge fund firm, Greenlight Capital, and obtained by Institutional…#greenlightcapital #einhorn #belgium #syensqo #greenlight #federalreserve #jaypowell #mylan #pfizer #solvay (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2024 Category: Consumer Health News Source Type: news
How COVID-19 Vaccines and Infections Are Tweaking Our Immunity
Your immune system may be getting smarter every time you encounter COVID-19, a new study suggests. After getting vaccinated and infected, the immune system generates broader defenses against the virus, including against new variants.
In a paper published Jan. 19 in Science Immunology, researchers in South Korea compared immune cells in the lab from people with a variety of vaccine and infection histories throughout the different Omicron waves, which began in late 2021 with BA.1. People who had been vaccinated with the original Pfizer-BioNTech series and then got infected with any Omicron variant showed good levels of me...
Source: TIME: Health - January 22, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Column: A bogus new attack on COVID vaccines from Texas' least credible politician
In recent times, whenever a government lawsuit swears at common sense, at the facts and at the public interest, it has been a safe bet that Texas Atty. Gen. Ken Paxton has his fingerprints on it. Sure enough, here comes Paxton with a lawsuit charging Pfizer Inc. with systematically misrepresenting…#texasatty #kenpaxton #paxton #pfizerinc #lubbock #pfizer #texans #omicron #commonwealthfund #republicans (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2024 Category: Consumer Health News Source Type: news
